Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Sickle Cell Disease
Interventions
DRUG

Arginine

"Arginine will be dispensed intravenously (in the vein) in the standard dose of arginine as 100 mg/kg three times a day for seven days or until discharge.~* Loading dose: 200 mg/kg once~* Continuous IV: 300 mg/kg/24 hours"

DRUG

Arginine (Loading)

Arginine will be dispensed intravenously (in the vein) as an initial bolus (loading) at each specified group dose once, followed by a standard dose of 100mg/kg every 8 hours until discharge or for a total of 21 doses of arginine, whichever comes first.

DRUG

Arginine (Continuous)

Arginine will be dispensed intravenously (in the vein) as a continuous IV infusion of 300 mg/kg/24hr

Trial Locations (2)

30303

RECRUITING

Children's Healthcare fo Atlanta at Hughes Spalding, Atlanta

30329

RECRUITING

Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta

Sponsors
All Listed Sponsors
collaborator

Children's Healthcare of Atlanta

OTHER

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

Emory University

OTHER